134 related articles for article (PubMed ID: 7526760)
41. Increased expression of gelatinases and collagenase in rat lungs exposed to 100% oxygen.
Pardo A; Selman M; Ridge K; Barrios R; Sznajder JI
Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):1067-75. PubMed ID: 8887609
[TBL] [Abstract][Full Text] [Related]
42. Dysregulated proteolytic balance as the basis of excess extracellular matrix in fibrotic disease.
Peters CA; Freeman MR; Fernandez CA; Shepard J; Wiederschain DG; Moses MA
Am J Physiol; 1997 Jun; 272(6 Pt 2):R1960-5. PubMed ID: 9227614
[TBL] [Abstract][Full Text] [Related]
43. Activation of tumor cell matrix metalloproteinase-2 by neutrophil proteinases requires expression of membrane-type 1 matrix metalloproteinase.
Schwartz JD; Shamamian P; Monea S; Whiting D; Marcus SG; Galloway AC; Mignatti P
Surgery; 1998 Aug; 124(2):232-8. PubMed ID: 9706143
[TBL] [Abstract][Full Text] [Related]
44. Regulatory mechanisms for the expression of type IV collagenases/gelatinases in murine macrophages.
Xie B; Dong Z; Fidler IJ
J Immunol; 1994 Apr; 152(7):3637-44. PubMed ID: 8144939
[TBL] [Abstract][Full Text] [Related]
45. Identification of soluble type of membrane-type matrix metalloproteinase-3 formed by alternatively spliced mRNA.
Matsumoto S; Katoh M; Saito S; Watanabe T; Masuho Y
Biochim Biophys Acta; 1997 Nov; 1354(2):159-70. PubMed ID: 9396633
[TBL] [Abstract][Full Text] [Related]
46. Metalloproteinase domain structure, cellular invasion and metastasis.
Cockett MI; Birch ML; Murphy G; Hart IR; Docherty AJ
Biochem Soc Trans; 1994 Feb; 22(1):55-7. PubMed ID: 8206283
[No Abstract] [Full Text] [Related]
47. Increased MMP-9 activity in acute carotid plaques: therapeutic avenues to prevent stroke.
Loftus IM; Goodall S; Crowther M; Jones L; Bell PR; Naylor AR; Thompson MM
Ann N Y Acad Sci; 1999 Jun; 878():551-4. PubMed ID: 10415770
[No Abstract] [Full Text] [Related]
48. In situ activity of gelatinases during Lewis lung carcinoma progression.
Tucker GC; Ferry G; Provent S; Atassi G
Ann N Y Acad Sci; 1999 Jun; 878():534-7. PubMed ID: 10415765
[No Abstract] [Full Text] [Related]
49. Comparative analysis of matrix metalloproteinases by immunocytochemistry, immunohistochemistry and zymography in human primary brain tumours.
Rooprai HK; Van Meter T; Rucklidge GJ; Hudson L; Everall IP; Pilkington GJ
Int J Oncol; 1998 Dec; 13(6):1153-7. PubMed ID: 9824624
[TBL] [Abstract][Full Text] [Related]
50. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2).
Fridman R; Toth M; Peña D; Mobashery S
Cancer Res; 1995 Jun; 55(12):2548-55. PubMed ID: 7780967
[TBL] [Abstract][Full Text] [Related]
51. Secretion of matrix metalloproteinase-2, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases into the intrauterine compartments during early pregnancy.
Riley SC; Leask R; Chard T; Wathen NC; Calder AA; Howe DC
Mol Hum Reprod; 1999 Apr; 5(4):376-81. PubMed ID: 10321811
[TBL] [Abstract][Full Text] [Related]
52. Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9.
Ochieng J; Fridman R; Nangia-Makker P; Kleiner DE; Liotta LA; Stetler-Stevenson WG; Raz A
Biochemistry; 1994 Nov; 33(47):14109-14. PubMed ID: 7947821
[TBL] [Abstract][Full Text] [Related]
53. Interaction of matrix metalloproteinases with serine protease inhibitors. New potential roles for matrix metalloproteinase inhibitors.
Mallya SK; Hall JE; Lee HM; Roemer EJ; Simon SR; Golub LM
Ann N Y Acad Sci; 1994 Sep; 732():303-14. PubMed ID: 7978799
[No Abstract] [Full Text] [Related]
54. Matrix metalloproteinase family.
Baramova E; Foidart JM
Cell Biol Int; 1995 Mar; 19(3):239-42. PubMed ID: 7606234
[No Abstract] [Full Text] [Related]
55. Activation of gelatinase-tissue-inhibitors-of-metalloproteinase complexes by matrilysin.
von Bredow DC; Cress AE; Howard EW; Bowden GT; Nagle RB
Biochem J; 1998 May; 331 ( Pt 3)(Pt 3):965-72. PubMed ID: 9560329
[TBL] [Abstract][Full Text] [Related]
56. A study of metalloproteinases in fifty joint fluid specimens.
Gaudin P; Razakaboay M; Surla A; Berthier S; Fauconnier J; Morel F; Phelip X
Rev Rhum Engl Ed; 1997 Jun; 64(6):375-81. PubMed ID: 9513609
[TBL] [Abstract][Full Text] [Related]
57. Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP).
Murphy G; Cockett MI; Ward RV; Docherty AJ
Biochem J; 1991 Jul; 277 ( Pt 1)(Pt 1):277-9. PubMed ID: 1649600
[TBL] [Abstract][Full Text] [Related]
58. Distribution of the matrix metalloproteinases stromelysin, gelatinases A and B, and collagenase in Crohn's disease and normal intestine.
Bailey CJ; Hembry RM; Alexander A; Irving MH; Grant ME; Shuttleworth CA
J Clin Pathol; 1994 Feb; 47(2):113-6. PubMed ID: 8132824
[TBL] [Abstract][Full Text] [Related]
59. Effects of parathyroid hormone (PTH) and PTH-related peptide on expressions of matrix metalloproteinase-2, -3, and -9 in growth plate chondrocyte cultures.
Kawashima-Ohya Y; Satakeda H; Kuruta Y; Kawamoto T; Yan W; Akagawa Y; Hayakawa T; Noshiro M; Okada Y; Nakamura S; Kato Y
Endocrinology; 1998 Apr; 139(4):2120-7. PubMed ID: 9529001
[TBL] [Abstract][Full Text] [Related]
60. Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A.
Okada A; Tomasetto C; Lutz Y; Bellocq JP; Rio MC; Basset P
J Cell Biol; 1997 Apr; 137(1):67-77. PubMed ID: 9105037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
